Better Buy: Johnson & Johnson vs. Merck
This big pharma claims one of the hottest cancer drugs around. But it also faces challenges for some of its biggest-selling drugs. Which big pharma is it?
Actually, it's two: Johnson & Johnson (NYSE: JNJ) and Merck (NYSE: MRK).
These companies are similar in several ways. However, Johnson & Johnson stock is up big in 2017, while Merck stock has lost ground this year. Will J&J continue to be the better pick, or will Merck roar back? Here's how these pharma stocks compare.
Source: Fool.com
Johnson & Johnson Stock
€147.96
0.490%
With 40 Buy predictions and 1 Sell predictions Johnson & Johnson is one of the favorites of our community.
As a result the target price of 187 € shows a positive potential of 26.39% compared to the current price of 147.96 € for Johnson & Johnson.
